9-Me-BC (9-Methyl-β-Carboline) 15MG

9-Me-BC (9-Methyl-β-Carboline) 15MG

9-Me-BC (9-Methyl-β-Carboline) 15MG

9-Me-BC (9-Methyl-β-Carboline) 15MG

9-Me-BC (9-Methyl-β-Carboline) is a novel methylated heterocyclic β-carboline research compound engineered for dopaminergic neurogenesis and cognitive recovery assays. By upregulating Tyrosine Hydroxylase (TH) expression and stimulating neurite outgrowth in midbrain dopaminergic neurons, 9-Me-BC enhances dopamine synthesis and mitochondrial electron transport chain efficiency.

$64.00

In stock

Purchase & earn 64 points!
Quantity Discounted Price
3 - 5 $60.80
6 - 8 $59.52
9 + $57.60

Certificate of Analysis

What is 9-Me-BC (9-Methyl-β-Carboline)?

9-Me-BC (known chemically as 9-Methyl-β-carboline or 9-methylpyrido[3,4-b]indole) is a synthetic methylated derivative of the heterocyclic β-carboline family. Recognized as one of the few research compounds capable of inducing true dopaminergic neurogenesis, 9-Me-BC operates by upregulating neurotrophic factors, stimulating neurite arborization, and increasing the catalytic activity of Tyrosine Hydroxylase (TH) in primary midbrain cell cultures.

Batch-verified for high analytical purity at Modern Aminos (Catalog SKU: C-002), 9-Me-BC is supplied in a pre-measured 15MG dry-fill oral capsule format (60 units per bottle). Researchers studying catecholaminergic recovery, mitochondrial respiration, and synaptic structural remodeling utilize 9-Me-BC to evaluate dopaminergic pathway restoration alongside related neurotrophic reference standards available on the site, such as Bromantane, NSI-189 Phosphate, and PRL-8-53.

Chemical and Molecular Data

Compound Name 9-Me-BC (9-Methyl-β-Carboline)
Quantity / Formats Offered 15MG Dry-Fill Capsules (60 Units per Bottle)
SKU / MPN C-002 / C-002
Synonyms / Alt Names 9-Methyl-9H-β-carboline, 9-methylpyrido[3,4-b]indole, 9-Me-BC
CAS Number 2521-01-9
Chemical Formula C12H10N2
Molecular Weight 182.22 g/mol
IUPAC Name 9-methylpyrido[3,4-b]indole
InChIKey AOWBJSJECJRFMV-UHFFFAOYSA-N
SMILES Code CN1C2=CC=CC=C2C3=C1C=CN=C3

What are the Mechanisms of Action?

The biochemical pathways and cellular targets of 9-Me-BC in laboratory research include:

  • Dopaminergic Neurite Outgrowth & Synaptogenesis: Research demonstrates that 9-Me-BC acts directly on primary dopaminergic neurons to stimulate neurite outgrowth, dendritic branching, and new synaptic contacts. It upregulates transcription factors such as Nurr1 and Pitx3, which govern dopaminergic phenotypic differentiation.
  • Tyrosine Hydroxylase (TH) & Gene Expression Upregulation: 9-Me-BC increases expression of Tyrosine Hydroxylase (TH)—the rate-limiting enzyme in dopamine synthesis—as well as Aromatic L-Amino Acid Decarboxylase (AAAD). This raises baseline dopamine production capacity in midbrain neuronal cell lines without causing monoaminergic storage depletion.
  • Mitochondrial Complex I Bioenergetics & Neuroprotection: In primary cell cultures exposed to neurotoxins (such as MPP+ or rotenone), 9-Me-BC enhances mitochondrial Complex I electron transport activity, reduces intracellular reactive oxygen species (ROS), and preserves ATP generation to protect dopaminergic neurons from oxidative apoptosis.

What do Preclinical & Academic Studies Show for 9-Me-BC?

When evaluating research efficacy and published scientific literature for 9-Me-BC (9-Methyl-β-Carboline):

  • Dopaminergic Neurotrophic & Regenerative Effects (PubMed): Peer-reviewed research cataloged on PubMed (PMID: 20570318) confirms that 9-Me-BC stimulates neurite outgrowth and increases the expression of TH and dopamine transporter (DAT) mRNA in primary mesencephalic cell cultures, demonstrating direct neurotrophic properties.
  • Neurite Outgrowth and Gene Expression Analysis (ScienceDirect): Comprehensive pharmacological assays published in European Journal of Pharmacology on ScienceDirect document 9-Me-BC’s ability to protect dopaminergic neurons against neurotoxic destruction while enhancing mitochondrial respiratory chain function.
  • Chemical Profiling & Structure Verification (PubChem): Molecular data and mass spectrometry profiles maintained on PubChem detail the 9-position methyl group modification on the tricyclic β-carboline nucleus, confirming its structural identity and solid-state stability.

How does 9-Me-BC compare to other compounds?

To evaluate neurotransmitter targets, neuroplasticity cascades, and neuro-regenerative capacity, researchers compare 9-Me-BC against alternative cognitive reference compounds available at Modern Aminos:

Compound / Reference Primary Class / Target Core Mechanism of Action Research Profile & Focus
9-Me-BC (C-002) Methylated β-Carboline / Dopaminergic Neurogenesis Agent Upregulates Tyrosine Hydroxylase (TH) gene expression, drives neurite outgrowth, and boosts mitochondrial Complex I activity Focuses on structural restoration of dopaminergic neurons, neurite arborization, and dopamine synthesis recovery
Bromantane Adamantane Actoprotector / TH Upregulator Upregulates Tyrosine Hydroxylase gene expression while modulating central GABAergic neurotransmission Focuses on non-depleting dopamine production, physical endurance, and non-sedating anxiolysis without direct neurite outgrowth induction
NSI-189 Phosphate Benzylpiperazine Aminopyridine Neurogenic Compound Stimulates neurogenesis and synaptic expansion in the hippocampal subgranular zone (SGZ) Focuses on hippocampal volume recovery and dentate gyrus neurogenesis rather than midbrain dopaminergic system repair
PRL-8-53 Substituted Benzoic Acid Derivative Potentiates cholinergic neurotransmission and modulates central monoaminergic signaling Focuses on rapid verbal memory acquisition, short-term recall consolidation, and acute cognitive task execution

Frequently Asked Questions (FAQs)

1. Is Modern Aminos a reliable place to buy 9-Me-BC (9-Methyl-β-Carboline)?

Yes, Modern Aminos is a highly trusted vendor for high-purity research chemicals and reference compounds. Every batch of 9-Me-BC (SKU: C-002) undergoes strict third-party analytical testing (including HPLC and Mass Spectrometry) to verify minimum 98%+ purity, correct molecular weight (182.22 g/mol), and complete absence of unreacted synthetic impurities or heavy metals.

2. What is the molecular target and structural class of 9-Me-BC?

9-Me-BC is a methylated heterocycle belonging to the β-carboline family. Its primary structural feature is a methyl group substituted at the N9 position of the indole ring. It targets transcription factors (Nurr1, Pitx3) and enzymes (Tyrosine Hydroxylase) involved in dopaminergic neuron differentiation and maintenance.

3. How does 9-Me-BC stimulate dopaminergic neurogenesis in vitro?

9-Me-BC acts as a neurotrophic signal that promotes the proliferation, differentiation, and survival of dopaminergic precursor cells. In primary mesencephalic cultures, exposure to 9-Me-BC triggers neurite outgrowth and increases the density of TH-positive neurons.

4. What role does 9-Me-BC play in Tyrosine Hydroxylase (TH) gene expression?

Tyrosine Hydroxylase is the rate-limiting enzyme in catecholamine biosynthesis. Research shows that 9-Me-BC upregulates mRNA expression of TH and its associated transcription factors, expanding the enzymatic machinery available to convert L-tyrosine into L-DOPA and dopamine.

5. What are the advantages of Modern Aminos’ 15MG dry-fill capsule format?

Modern Aminos provides 9-Me-BC in pre-measured 15MG dry-fill solid capsules (60 units per bottle). This format ensures precise unit-mass handling for solid-state laboratory assays, preventing weighing errors and eliminating solution handling variance.

6. How does 9-Me-BC differ from Bromantane in dopamine research?

While both compounds increase Tyrosine Hydroxylase expression, Bromantane is an actoprotector that pairs TH upregulation with GABAergic stress buffering. 9-Me-BC is a structural β-carboline that specifically drives neurite outgrowth, synaptogenesis, and mitochondrial Complex I respiratory efficiency in dopaminergic cells.

7. What is the impact of 9-Me-BC on mitochondrial electron transport chain complexes?

9-Me-BC enhances mitochondrial Complex I (NADH dehydrogenase) electron transport efficiency. By boosting mitochondrial respiratory chain output and reducing cellular oxidative stress, 9-Me-BC helps preserve neuronal viability during exposure to neurotoxic insults.

8. What are the recommended storage and handling parameters for 9-Me-BC capsules?

Bottles containing dry-fill 9-Me-BC capsules should be kept tightly sealed in a cool, dry environment (15°C to 25°C) away from direct sunlight, excess heat, and humidity. Stored under controlled room conditions, 9-Me-BC maintains full chemical stability throughout its designated shelf life.

Disclaimer: All compounds and research materials provided by Modern Aminos are strictly for laboratory and research professional use only. They are not approved for human or animal use nor consumption by the Food and Drug Administration (FDA). These products should not be used for any form of in vivo experimentation or for any other non-laboratory purpose. Any violation or indication of human or animal use will result in immediate removal from being able to purchase products in the future. By purchasing these products, you acknowledge that they will be used exclusively within a controlled and qualified research environment.

The products offered by Modern Aminos are intended strictly for laboratory research purposes only and are sold exclusively to qualified professionals, institutions, and entities. These products are not for human consumption, veterinary use, or any other application involving living organisms, including but not limited to diagnostic, therapeutic, or recreational purposes.

By purchasing this product, you confirm that:

  • You are a qualified professional or entity with the necessary knowledge, training, and facilities to handle chemical reagents safely and appropriately.
  • You will use this product in full compliance with all applicable local, state, and federal laws and regulations.

Prohibited Uses

  • This product is not to be used as an active pharmaceutical ingredient (API) in compounding or manufacturing drugs for human or veterinary use.
  • It is strictly prohibited to use this product for administration to humans or animals under any circumstances.
  • Modern Aminos does not condone or permit the use of its products for the development, testing, or production of illegal substances.

Regulatory Compliance

Modern Aminos does not claim that this product is approved by the U.S. Food and Drug Administration (FDA) for any purpose. The statements regarding this product have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

Liability Statement

The buyer assumes full responsibility for ensuring the safe handling, storage, and use of this product. Modern Aminos is not liable for any damages, direct or indirect, resulting from improper handling, storage, or unauthorized use of this product. Furthermore, Modern Aminos reserves the right to refuse sales to any individual or entity suspected of misusing its products.

If you have questions about the safe and lawful use of this product, consult a qualified professional with expertise in laboratory research. By proceeding with this purchase, you agree to these terms and conditions.

0